Referanslar

Nedir?

  1. HIV/AIDS: Temel Bilgiler. https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets, Site Updated: November 22, 2017
  2. CD4, viral yük & diğer testler. https://www.aidsmap.com, 2017

Nasıl Bulaşır?

  1. HIV/AIDS: Temel Bilgiler. https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets, Site Updated: November 22, 2017
  2. HIV'i Önlemenin Temelleri. https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets, Site Updated: November 22, 2017
  3. Temel Sağlık Hizmetleri Genel Müdürlüğü, Bulaşıcı Hastalıkların Kontrolü Daire Başkanlığı, 2016 verileri
  4. Tümer A. HIV/AIDS Epidemiyolojisi ve Korunma Hacettepe Üniversitesi HIV/AIDS Tedavi ve Araştırma Merkezi Yayını 5.Mart.2013
  5. Eren Ş, Taşdelen-Fışgın N, Baykam N, Çelikbaş AK, Güven T, Dokuzoğuz B. HIV/AIDS Olgularında Ölüm Nedenleri. Turk J HIV/AIDS 2003;6(4):113-6.
  6. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150(3): 306-311.
  7. Punar M, Uzel S, Cemil EH, Çağatay AA, Özsüt H, Eraksoy H, Dilmener M. HIV Enfeksiyonu: 44 Vakanın Analizi Klimik Dergisi 2000:13(3):94-97
  8. Erbay A, Bodur H, Çolpan A, Akıncı E, Korkmaz M, Eren S. IV/AIDS Olgularının Değerlendirilmesi Turk J HIV/AIDS 2003;6(2):43-6.
  9. Baggaley RF, Boily MC, White RG, Alary M. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS 2006; 20(6): 805-812.
  10. Taşdelen Fışgın N, Tanyel E, Sarıkaya Genç H, Tülek N. HIV/AIDS Olgularının Değerlendirilmesi Klimik Dergisi 2009;22(1):18-20.
  11. Boily MC, Baggaley RF, Wang L, Masse B, White RG, Hayes RJ, Alary M. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9(2): 118-129.
  12. Baggaley RF, White RG, Boily MC, HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010; 39(4): 1048-1063.
  13. Mumtaz G, Hilmi N, McFarland W, Kaplan RL, Akala FA, Semini I, Riedner G, Tawil O, Wilson D, Abu-Raddad LJ.Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: a systematic review and data synthesis.PLoS Med. 2010 Aug;8(8):e1000444.
  14. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ. 2004;82:454–461.
  15. CDC. Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR 1985;34:1-5.
  16. CDC. Testing donors of organs, tissues, and semen for antibody to human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR 1985;34:294.
  17. CDC. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. MMWR 1994;43(No. RR-8).
  18. Marcos Y, Phelps BR, Bachman G. Community strategies that improve care and retention along the prevention of mother-to-child transmission of HIV cascade: a review. J Int AIDS Soc. 2012 Jul 11;15 Suppl 2:17394.
  19. Busza J, Walker D, Hairston A, Gable A, Pitter C, Lee S, Katirayi L, Simiyu R, Mpofu D.Community-based approaches for prevention of mother to child transmission in resource-poor settings: a social ecological review.J Int AIDS Soc. 2012 Jul 11;15 Suppl 2:17373.

Tedavi

  1. https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/21/51/hiv-treatment--the-basics
  2. Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE; HIV Medicine Association of the Infectious Diseases Society of America. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009 Sep 1;49(5):651-81.
  3. Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M; Swiss HIV Cohort Study Group. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med. 2003 Oct 13;163(18):2187-95.
  4. Horowitz HW, Telzak EE, Sepkowitz KA, Wormser GP. Human immunodeficiency virus infection, Part I. Dis Mon. 1998 Oct;44(10):545-606.
  5. Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73.
  6. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d'Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet. 1998 Nov 28;352(9142):1725-30.
  7. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.N Engl J Med. 1998 Mar 26;338(13):853-60.
  8. Vittinghoff E, Scheer S, O'Malley P, Colfax G, Holmberg SD, Buchbinder SP. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.J Infect Dis. 1999 Mar;179(3):717-20.
  9. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV1-infected adults and adolescents. Department of Health and Human Services. Erişim: http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf May 5, 2013;1-P23
  10. Garcia de Olalla P., Knobel H., Carmona A., Guelar A., Lopez-Colom JL., Cayla JA. Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients. J Acquir Immune Defic Syndr 2002, 30(1): 105-110.
  11. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N.Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000 Jul 4;133(1):21-30.
  12. Baykam N. Antiretroviral Tedavide Uyum Sorunu. I. Ulusal AIDS Savaşım Sempozyumu 28 Kasım-1 Aralık 2002 Ankara, Sempozyum Özet Kitabı: 36-37.
  13. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med. 2003 Nov 18;139(10):810-6.
  14. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, Moss A. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.AIDS. 2001 Jun 15;15(9):1181-3.
  15. Scalera A, Bayoumi AM, Oh P, Risebrough N, Shear N, Tseng AL. Clinical and Economic Implications of Non-Adherence to HAART in HIV Infection Dis Manag Health Outcomes 2002; 10(2):85-91
  16. Kalishman SC., Ramachandran B., Catz S. Adherence to Combination Antiretroviral Therapies in HIV Patients of Low Health Literacy. J Gen Intern Med 1999, 14:267-273.
  17. Kemppainen JK. Levine RE., Mistal M., Schmidgall D. HAART Adherence in Culturally diversi Patients with HIV/ AIDS: A Study of Male Patients from a Veteran’s Administration Hospital in Nothern California. AIDS Patient Care and STDs 2001, 15(3):117-126.
  18. Proctor VE., Tesfa A., Tombkins DC. Barriers to Adherence to Higly Active Antiretroviral Therapy as Expressed by People Living with HIV/AIDS. AIDS Patient Care and STDs 1999 , 13(9):535-544.
  19. Friedland GH. Adherence: The Achilles' Heal of Highly Active Antiretroviral Therapy. Improving the management of HIV disease Int AIDS Soc USA 1997;5(1):13-15.
  20. Kelly JA, Otto-Salaj LL, Sikkema KJ, Pinkerton SD, Bloom FR.Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention.Health Psychol. 1998 Jul;17(4):310-9.
  21. Catz SL, Heckman TG, Kochman A, Dimarco M. Rates and correlates of HIV treatment adherence among late middle-aged and older adults living with HIV disease. Psychology, Health&Medicine 2001;6(1):47-58
  22. Murphy DA, Roberts KJ, Martin DJ, Marelich W, Hoffman D.Barriers to antiretroviral adherence among HIV-infected adults.AIDS Patient Care STDS. 2000 Jan;14(1):47-58.
  23. Wright MT.The old problem of adherence: research on treatment adherence and its relevance for HIV/AIDS. AIDS Care. 2000 Dec;12(6):703-10.
  24. Blechner M. Hope and Mortality: Pschodynamic Approaches to AIDS and HIV. Psychoanalytic Psychology 2000;17(1):190-193.
  25. Simoni JM, Frick PA, Pantalone DW, Turner BJ. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003 Nov-Dec;11(6):185-98.
  26. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication compliance and persistence: terminology and definitions. Value Health. 2008 Jan-Feb;11(1):44-7
  27. Mannerheimer S, Friedland G, Matts J, Chen L, Child C, MacArthur R, Kostman J, Brizz B, Chesney M. Self-reported antiretroviral adherence correlantes with HIV liral load and declines over time. Int Conf AIDS. 2000 Jul 9-14;13:abstract no. TuOrB421.
  28. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999 Jul 20;131(2):81-7.
  29. Rastegar DA, Fingerhood MI, Jasinski DR.Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care. 2003 Apr;15(2):231-7.
  30. Berg MB, Safren SA, Mimiaga MJ, Grasso C, Boswell S, Mayer KH. Nonadherence to medical appointments is associated with increased plasma HIV RNA and decreased CD4 cell counts in a community-based HIV primary care clinic. AIDS Care. 2005 Oct;17(7):902-7.
  31. Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, Chaisson RE, Maartens G.Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S127-33.
  32. Amuron B, Namara G, Birungi J, Nabiryo C, Levin J, Grosskurth H, Coutinho A, Jaffar S. Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health. 2009 Aug 11;9:290
  33. Giordano TP, Gifford AL, White AC Jr, Suarez-Almazor ME, Rabeneck L, Hartman C, Backus LI, Mole LA, Morgan RO.Retention in care: a challenge to survival with HIV infection.Clin Infect Dis. 2007 Jun 1;44(11):1493-9.
  34. Rosen S, Fox MP, Gill CJ.Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review.PLoS Med. 2007 Oct 16;4(10):e298.
  35. Jarrett O, Mwamburi M. Patient Outcomes in a Public Sector ART Program in Rural Kenya and Patient Characteristics of Those who Remain In-care vs. Lost to Follow-up. Paper presented at Fifth IAS Conference on HIV Pathogenesis, Treatment and Prevention, Cape Town, South Africa, July 19–22; abstract no. MOPED052.
  36. Friedland GH, Mannheimer S, Matts J, Child C, Telzak E, Chesney M. Duration of antiretroviral adherence predicts biologic outcomes in clinical trials. The 1st. IAS Conference on HIV Pathogenesis and Treatment : Abstract no. 33
  37. Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS. 2001 Jul 27;15(11):1369-77.
  38. Parienti JJ, Bangsberg DR, Verdon R, Gardner EM. Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis. 2009 Feb 15;48(4):484-8.
  39. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, Weinstein MC, Freedberg KA. The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006 Jul 1;194(1):11-9
  40. World Health Organization. Human immunodeficiency virus and acquired immunodeficiency syndrome. İçinde: Adherence to Long-Term Theraphies. 2003:95-106
  41. Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes, 1998:18:117–125.
  42. Golin CE, Liu H, Hays RD, Miller LG, Beck CK, Ickovics J, Kaplan AH, Wenger NS. A prospective study of predictors of adherence to combination antiretroviral medication.J Gen Intern Med. 2002 Oct;17(10):756-65.

Dünya'da HIV

  1. http://www.who.int/hiv/data/en/, 2017.
  2. Del Rio C, Curan JW. Epidemiology and prevention of acquired immuno deficiency syndrome and human immuno deficiency virus infection. Editörler: Mandell GL, Bennett JE, Dolin R, Mandell Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Elsevier Churchill Livingstone;2010:1635-61.

Türkiye'de HIV

  1. Tümer A. HIV/AIDS nedir? Hacettepe Üniversitesi HIV/AIDS Tedavi ve Araştırma Merkezi Yayını 5.Mart.2013
  2. Temel Sağlık Hizmetleri Genel Müdürlüğü, Bulaşıcı Hastalıkların Kontrolü Daire Başkanlığı, 2016 verileri
  3. Tümer A. HIV/AIDS Epidemiyolojisi ve Korunma Hacettepe Üniversitesi HIV/AIDS Tedavi ve Araştırma Merkezi Yayını 5.Mart.2013
  4. Eren Ş, Taşdelen-Fışgın N, Baykam N, Çelikbaş AK, Güven T, Dokuzoğuz B. HIV/AIDS Olgularında Ölüm Nedenleri. Turk J HIV/AIDS 2003;6(4):113-6.

Vücudum » Kemik

  1. Brown TT and Qaqish RB, Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review; AIDS 2006, 20:2165–2174
  2. McComsey et al, Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers, HIV/AIDS, CID 2010:51
  3. National Osteoporosis Society, Osteoporosis drugs. Available at: https://nos.org.uk/about-osteoporosis/treating-osteoporosis/osteoporosis-drugs/. Last accessed August 2017
  4. National Osteoporosis Society. Lifestyle choices. Available at: https://nos.org.uk/about-osteoporosis/prevention-are-you-at-risk/lifestyle-choices/. Last accessed August 2017
  5. National Osteoporosis Society, Healthy eating for strong bones, Balanced diet for bones. Available at: https://nos.org.uk/about-osteoporosis/prevention-are-you-at-risk/a-balanced-diet-for-bones/, Last accessed September 2017
  6. National Osteoporosis Society, What is osteoporosis. Available at: https://nos.org.uk/about-osteoporosis/what-is-osteoporosis/. Last accessed August 2017
  7. EACS Guidelines 8.2 January 2017

Vücudum » Kanser

  1. Vogel, M. et al 2011, Cancer risk in HIV-infected individuals on HAART is largely attributed to oncegenic infections and state of immunocompetence, European Journal of Medical Research, 2011; 16(3): 101–107. Published online 2011 Mar 28. doi: 10.1186/2047-783X-16-3-101 [Accessed September 2o17]
  2. National Cancer Institute. HIV Infection and Cancer Risk, 2011. Available at www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hiv-fact-sheet [Accessed September 2017]
  3. National Cancer Institute. Cancer types. Available at: www.cancer.gov/types. [Accessed September 2017]
  4. WHO regional office for Europe. Cancer data and statistics. Available at: www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer/data-and-statistics [Accessed September 2017]
  5. Cancer Research UK. Why is early diagnosis important? Available at: http://www.cancerresearchuk.org/about-cancer/cancer-symptoms/why-is-early-diagnosis-important [Last accessed August 2017]
  6. 6 NHS Choices – Glandular Fever. Available at http://www.nhs.uk/conditions/Glandular-fever/Pages/Introduction.aspx. Accessed September 2017
  7. EACS Guidelines 2017 , version 8.2., January 2017
  8. European Commission. European guidelines or quality assurance in colorectal cancer screening and diagnosis. 2010 http://www.kolorektum.cz/res/file/guidelines/CRC-screening-guidelines-EC-2011-02-03.pdf page 66
  9. Cancer Research UK. About Anal Cancer. http://www.cancerresearchuk.org/about-cancer/anal-cancer/risks-causes accessed September 2017
  10. Lung cancer: who's at risk? – NHS Choices http://www.nhs.uk/Livewell/Lungcancer/Pages/Lungcancerareyouatrisk.aspx accessed September 2017
  11. Lymphoma and HIV | Lymphoma Association. https://www.lymphomas.org.uk/about-lymphoma/types/lymphoma-and-hiv#why-hiv-risk-lymphoma accessed September 2017

Vücudum » Diyabet

  1. Asif M. The prevention and control the type-2 diabetes by changing lifestyle and dietary pattern. J Educ Health Promot 2014; 3(1):1. doi: 10.4103/2277-9531.127541.
  2. Brown T, Cole S, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165:1179–1184.
  3. Diabetes UK. Diabetes risk factors, Preventing Type 2 diabetes. Available at: https://www.diabetes.org.uk/Preventing-Type-2-diabetes/Diabetes-risk-factors/ [Accessed: 17 July 2017]
  4. Diabetes UK. Living with diabetes, Guide to Diabetes. Available at: https://www.diabetes.org.uk/Guide-to-diabetes [Accessed: 25 August 2017]
  5. Diabetes UK. Diabetes: The Basics. Available at: https://www.diabetes.org.uk/Preventing-Type-2-diabetes/Diabetes-risk-factors/ [Accessed: 14 July 2017]
  6. Kalra S, Kalra B, Agrawal N, et al. Understanding diabetes in patients with HIV/AIDS. Diabetology & Metabolic Syndrome 2011, 3:2.

Vücudum » Kalp

  1. Triant V.A, Cardiovascular Disease and HIV Infection, HIV/AIDS 2013 10(3): 199–206. doi:10.1007/s11904-013-0168-6
  2. Zaaqoq et al. Cardiovascular Complications of HIV-Associated Immune Dysfunction, Cardiology Research and Practice 2015, Article ID 302638
  3. Piepoli et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice, European Heart Journal 2016, 37, 2315–2381
  4. Shahbaz et al. 2015 Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?, World Journal of Cardiology 2015, October 26; 7(10): 633-644
  5. NHS Choices 2017, Coronary heart disease – Treatment, Conditions (accessed 31 August 2017)
  6. http://www.nhs.uk/Conditions/Coronary-heart-disease/Pages/Treatment.aspx
  7. NHC Choices 2017, Cardiovascular disease, Introducation, Conditions (accessed 31 August 2017)
  8. http://www.nhs.uk/Conditions/cardiovascular-disease/Pages/Introduction.aspx#types
  9. Serrano, M. et al 2003, Smoking cessation and risk of myocardial reinfarction in coronary patients: a nested case-control study, Revista Espanola De Cardiologia, 2003;56:445-51 - Vol. 56 Num.05

Vücudum » Böbrek

  1. Winston, J. Kidney didease in patients with HIV infection and AIDS. CID 2008:47 1449-1457
  2. Chronic kidney disease - Living with - NHS Choices. http://www.nhs.uk/Conditions/Kidney-disease-chronic/Pages/living-with.... Last accessed September 2017
  3. Operskalski, E. Curr HIV/AIDS Rep. 2011 Mar; 8(1): 12–22. Published online 2011 Jan 11. doi: 10.1007/s11904-010-0071-3 PMCID: PMC3035774. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035774/
  4. European Renal Association. Leading European Nephrology. Prevalence of Chronic Kidney Disease, 2016. Available at: http://era-edta.org/press/160104_CKD_Prevelance_Press.pdf
  5. NHS Choices 2017, Chronic Kidney Disease, Available at http://www.nhs.uk/conditions/kidney-disease-chronic/pages/introduction.aspx. Accessed September 2017
  6. Maggi, P. Renal Complications in HIV Disease: Between Present and Future. AIDS Rev. 2012;14:37-53
  7. EACS Guidelines 2017 , version 8.2., January 2017
  8. NHS Choices. Preventing Chronic Kidney Disease. Available at: http://www.nhs.uk/Conditions/Kidney-disease-chronic/Pages/Prevention.aspx. Accessed September 2017
  9. Jones, L et al. 2011, Chronic adverse effects associated with the use of cocaine, Cocaine, A summary of the health harms of drugs, 2011 p.6

Vücudum » Karaciğer

  1. NAMaidsmap, HIV & Aids Informations: Factsheet the Liver. Available at: http://www.aidsmap.com/The-liver/page/1045123/ [Accessed: August 2017]
  2. British Liver Trust, Diet & Liver Disease. Available at: https://www.britishlivertrust.org.uk/liver-information/diet-and-liver-disease/. [Accessed August 2017]
  3. Aids Info, Side effects of HIV medicines, HIV and Hepatotoxicity, Understanding HIV, facts sheets. Availble at: https://aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/22/67/hiv-and. [Accessed August 2017] Frith, J et al. Chronic liver disease in an ageing population. Age and Ageing 2009; 38, 1, 11–18
  4. NHS Choices, Hepatitis A. Available at: http://www.nhs.uk/conditions/Hepatitis-A/Pages/Introduction.aspx [Accessed August 2017]
  5. NHS Choices, Hepatitis B/ http://www.nhs.uk/conditions/Hepatitis-B/Pages/Introduction.aspx [Accessed August 2017]
  6. NHS Choices, Hepatitis C. Available at: http://www.nhs.uk/conditions/Hepatitis-C/Pages/Introduction.aspx [Accessed August 2017]
  7. NHS Choices , Alcohol-related liver disease. Available at : http://www.nhs.uk/conditions/liver_disease_(alcoholic)/pages/introduction.aspx [Accessed August 2017]
  8. NHS Choices, Non-alcoholic fatty liver disease (NAFLD) Available at: http://www.nhs.uk/conditions/fatty-liver-disease/Pages/Introduction.aspx. [Accessed August 2017]
  9. Guraldi, G et al. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: Prevalence, characteristics, and predictors. Clinical infectious Diseases 2008: 47 250-7

Vücudum » Akciğer

  1. Benito, N. et al. Pulmonary infections in HIV-infected patients: an update in the 21st century ; European Respiratory Journal 2012 39: 730-745, DOI: 10.1183/09031936.00200210
  2. HIV & AIDS Information: Factsheet the lungs. http://www.aidsmap.com/The-lungs/page/1045132/. Last accessed September 2017
  3. Mirrakhimov, A. et al. Human Immunodeficiency Virus and Pulmonary Arterial Hypertension IRSN Cardiology. Volume 2013, Article ID 903454
  4. How CD4 and viral load are related. http://i-base.info/ttfa/section-2/14-how-cd4-and-viral-load-are-related/. Last accessed September 2017
  5. NHS Choices. Chest Infection, Introduction. Available at: http://www.nhs.uk/conditions/Chest-infection-adult/Pages/Introduction.aspx. [Accessed September 2017]
  6. C Dyer. The interaction of ageing and lung disease. Chronic Respiratory Disease 2012; 9(1) 63–67
  7. Helleberg, M. et al. Mortality attributable to smoking among HIV-1 Infected individuals: A nationwide, population-based cohort study, March 2013 CID: 56(5) 727-34
  8. NHS choices. Lung cancer. Available at http://www.nhs.uk/conditions/cancer-of-the-lung/Pages/Introduction.aspx Accessed September 2017

Vücudum » Ruh Sağlığı

  1. NHS Digital. Health Survey for England 2014; Mental Health problems. Health and Social Care Information Centre. http://content.digital.nhs.uk/catalogue/PUB19295 Last accessed August 2017
  2. Causes. Mind, the mental health charity – help for mental health problems. https://www.mind.org.uk/information-support/types-of-mental-health-problems/mental-health-problems-introduction/causes/#.WafIOcaQyUk. Last accessed August 2017
  3. R Bhatia et al. Persons Newly Diagnosed with HIV. AIDS Behave. 2011 August ; 15(6): 1161–1170
  4. M.S. Bhatia and S Munjal. Prevalence of Depression in People Living with HIV/AIDS Undergoing ART and Factors Associated with it J Clin Diagn Res. 2014 Oct; 8(10)
  5. D Saylor et al. HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment Nat Rev Neurol. 2016 April ; 12(4): 234–248.
  6. NHS Choices; Clinical Depression – Symptoms. Last accessed August 2017
  7. NHS Choices; Generalised anxiety disorder – Symptoms. Last accessed August 2017
  8. R Durvasula and T Miller. Substance Abuse Treatment in Persons with HIV/AIDS:Challenges in Managing Triple Diagnosis Behav Med. 2014 ; 40(2): 43–52
  9. Nam AIDSmap Antiretroviral drugs chart 2016 http://www.aidsmap.com/v636108409673330000/file/1213110/drug_chart_Sep_2016_WEB_ready.pdf Last accessed August 2017
  10. Gellago, L. et al, ‘Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz’, Brief report, HIV/AIDS, Clinical Infectious Diseases 2004; 38:430–2

Erkek ve Kadın Sağlığı » Aktif Yaşam

  1. NAMaidsmap Exercise available at: www.aidsmap.com/Exercise/page/1188930 accessed September 2017
  2. NHS Choices Physical Activity Guidelines Available at: www.nhs.uk/Livewell/fitness/Pages/physical-activity-guidelines-for-adults.aspx access September 2017

Erkek ve Kadın Sağlığı » Sigara Kullanımı

  1. European Society of Cardiology. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. 2016
  2. NHS Choices. 10 self-help tips to stop smoking. www.nhs.uk/Livewell/smoking/Pages/Motivateyourself.aspx Last Accessed September 2017
  3. NHS Choices. How much is smoking costing you? Available at: http://www.nhs.uk/Tools/Documents/Smoking%20calculator.html. Last accessed September 2017

Erkek ve Kadın Sağlığı » Sağlıklı Beslenme

  1. NAMaidsmap Drug Chart available at: www.aidsmap.com/v636108409673330000/file/1213110/drug_chart_Sep_2016_WEB_ready.pdf accessed September 2017
  2. Baril JG et al. HIV-associated lipodystrophy syndrome: A review of clinical aspects. Can J Infect Dis Med Microbiol. 2005 16(4):233-243
  3. NHS, (2016). Why 5 A DAY? - Live Well - NHS Choices. [online] Nhs.uk. Available at: http://www.nhs.uk/Livewell/5ADAY/Pages/Why5ADAY.aspx [Accessed September 2017].
  4. NHS, (2016). How to have a balanced diet - Healthy living - NHS Choices. [online] Nhs.uk. Available at: http://www.nhs.uk/Livewell/Goodfood/Pages/Healthyeating.aspx [Accessed September 2017].
  5. Zaaqoq et al. Cardiovascular Complications of HIV-Associated Immune Dysfunction, Cardiology Research and Practice 2015, Article ID 302638
  6. BMI Calculator - Body Mass Chart, BMI Formula and History. https://www.diabetes.co.uk/bmi.html accessed September 2017
  7. British Heart Foundation. Managing your weight. Available at https://www.bhf.org.uk/heart-health/preventing-heart-disease/managing-your-weight accessed September 2017

Erkek Sağlığı » Cinsel Sağlık

  1. EACS Guidelines 8.2, 2017
  2. Avert – Treatment as Prevention (TASP) for HIV. Available at https://www.avert.org/professionals/hiv-programming/prevention/treatment-as-prevention#footnote1_7uab43q Accessed October 2017
  3. NAMaidsmap. Sexual Dysfunction. Available at http://www.aidsmap.com/Sexual-dysfunction/page/1044891/ Accessed September 2017

Kadın Sağlığı » Menapoz

  1. NAMaidsmap. Menopause and HIV. Available at: http://www.aidsmap.com/Menopause-and-HIV/page/3117291/. Accessed September 2017
  2. Imai, K. HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy. Obstet Gynecol Int. 2013; 2013: 340309. Published online 2013 Dec 19. doi: 10.1155/2013/340309
  3. Guilherme Amaral Calvet MD, PhD et al. Predictors of early menopause in HIV-infected women: a prospective cohort study. American Journal of Obstetrics and Gynecology. Volume 212, Issue 6, June 2015, Pages 765.e1-765.e13
  4. Brown TT and Qaqish RB, Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review; AIDS 2006, 20:2165–2174
  5. NHS Choices. Menopause. Available at: http://www.nhs.uk/conditions/menopause/Pages/Introduction.aspx. Accessed September 2017.
  6. Eastell, R. Identification and management of osteoporosis in older adults. Medicine in older adults 2016

Kadın Sağlığı » Cinsel Sağlık

  1. EACS Guidelines 8.2, 2017,
  2. Avert – Treatment as Prevention (TASP) for HIV. Available at https://www.avert.org/professionals/hiv-programming/prevention/treatment-as-prevention#footnote1_7uab43q Accessed October 2017
  3. NAMaidsmap. Sexual Dysfunction. Available at http://www.aidsmap.com/Sexual-dysfunction/page/1044891/ Accessed September 2017

Kadın Sağlığı » Çocuk Sahibi Olma

  1. Conception – NAM Aidsmap (Last accessed September 2017) http://www.aidsmap.com/Conception/page/1550309/#item1550342
  2. Thinking about having a baby – Terrence Higgins Trust (Last accessed September 2017) http://www.tht.org.uk/myhiv/Staying-healthy/Parenthood/Thinking-about-having-a-baby
  3. EACS Guidelines 8.2. January 2017
  4. Stop smoking in pregnancy – NHS Choices - http://www.nhs.uk/conditions/pregnancy-and-baby/pages/smoking-pregnant.aspx
  5. Drinking alcohol whilst pregnant – NHS Choices - http://www.nhs.uk/Conditions/pregnancy-and-baby/pages/alcohol-medicines-drugs-pregnant.aspx
  6. Have a Healthy diet in pregnancy – NHS Choices - http://www.nhs.uk/conditions/pregnancy-and-baby/pages/healthy-pregnancy-diet.aspx
  7. Why do I need folic acid in pregnancy – NHS Choices - http://www.nhs.uk/chq/pages/913.aspx?categoryid=54
  8. Having a baby – NAM AIDSMap http://www.aidsmap.com/v634336406068830000/file/1050017/Having_a_baby_pdf.pdf (last accessed September 2017)
  9. Breastfeeding and post-natal care – Terrence Higgins Trust - http://www.tht.org.uk/myhiv/Staying-healthy/Parenthood/After-the-birth
  10. World Health Organisation. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach 2010 version, p. 1-106